337519-98-9

Basic information

• Product Name: 3-((E)-3-{4-[1-(t-butoxycarbonyl)piperidin-4-yloxy]phenylamino}-1-propenyl)benzonitrile
• Synonyms: 3-((E)-3-{4-[1-(t-butoxycarbonyl)piperidin-4-yloxy]phenylamino}-1-propenyl)benzonitrile
• CAS NO: 337519-98-9
• Molecular Weight: 433.55
• Mol File: 337519-98-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-((E)-3-{4-[1-(t-butoxycarbonyl)piperidin-4-yloxy]phenylamino}-1-propenyl)benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-((E)-3-{4-[1-(t-butoxycarbonyl)piperidin-4-yloxy]phenylamino}-1-propenyl)benzonitrile(337519-98-9)
• EPA Substance Registry System: 3-((E)-3-{4-[1-(t-butoxycarbonyl)piperidin-4-yloxy]phenylamino}-1-propenyl)benzonitrile(337519-98-9)

Safety Data

• Hazardous Substances Data: 337519-98-9(Hazardous Substances Data)

Upstream product

• 24964-64-5 3-Cyanobenzaldehyde 
• 475504-76-8 C₂₆H₂₉N₃O₃ 
• 141-78-6 ethyl acetate 
• 98116-49-5 3-cyano-1-(2-formylethenyl)benzene 
• 138227-63-1 tert-butyl 4-(4-aminophenoxy)piperidine-1-carboxylate 
• 138227-62-0 tert-butyl 4-(4-nitrophenoxy)piperidine-1-carboxylate 
• 100-02-7 4-nitro-phenol 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 123-30-8 4-amino-phenol 

Downstream Products

• 337520-11-3 3-[3-[N-[4-(1-t-butoxycarbonylpiperidin-4-yloxy)phenyl]-N-(2-hydroxyethyl)amino]-1-(E)-propenyl]benzonitrile 
• 337520-04-4 N-{4-[1-(t-butoxycarbonyl)piperidin-4-yloxy]phenyl}-N-[(E)-3-(3-cyanophenyl)-2-propenyl]-2-hydroxyacetamide 
• 337520-00-0 3-[3-[N-[4-(1-t-Butoxycarbonylpiperidin-4-yloxy)phenyl]-N-ethylamino]-1-(E)-propenyl]benzonitrile 
• 337520-05-5 Ethyl 2-[N-[4-(1-t-butoxycarbonylpiperidin-4-yloxy)phenyl]-N-[3-(3-cyanophenyl)-2-(E)-propenyl]amino]acetate 
• 337520-06-6 Ethyl 2-[N-[4-(1-t-butoxycarbonylpiperidin-4-yloxy)phenyl]-N-[3-(3-cyanophenyl)-2-(E)-propenyl]amino]propionate 
• 337520-03-3 N-{4-[1-(t-butoxycarbonyl)piperidin-4-yloxy]phenyl}-N-[(E)-3-(3-cyanophenyl)-2-propenyl]acetamide 
• 337519-99-0 3-[(E)-3-(N-{4-[1-(t-butoxycarbonyl)piperidin-4-yloxy]phenyl}-N-methylamino)-1-propenyl]benzonitrile 
• 337520-01-1 3-[3-[N-[4-(1-t-butoxycarbonylpiperidin-4-yloxy)phenyl]-N-isopropylamino]-1-(E)-propenyl]benzonitrile 
• 475504-77-9 C₃₀H₃₅N₃O₆ 
• 454437-24-2 3-(3-{4-[(1-tert-butoxycarbonyl-4-piperidyl)oxy]anilino}propyl)benzonitrile 

Relevant articles and documents

Cinnamyl derivatives: Synthesis and factor Xa (FXa) inhibitory activities

To develop a potent and oral anticoagulant, a series of compounds with cinnamyl moiety was synthesized and their factor Xa (FXa) inhibitory activities were examined. As a result, some cinnamyl derivatives showed potent FXa inhibitory activities in vitro. Among them, compounds with substituent at the 3-position on the central benzene ring represented by (N-{4-[1-(acetimidoyl) piperidin-4-yloxy]-3-chlorophenyl}-N-[(E)-3-(3-amidinophenyl)-2-propenyl] sulfamoyl)acetic acid dihydrochloride (45b) and (N-{4-[1-(acetimidoyl)piperidin- 4-yloxy]-3-carbamoylphenyl}-N-[(E)-3-(3-amidinophenyl)-2-propenyl]sulfamoyl) acetic acid dihydrochloride (45j) exhibited potent FXa inhibitory activities with IC50 values of less than 10 nM in vitro. These compounds also showed potent anticoagulant activities both in vitro and ex vivo. Furthermore, these compounds exhibited no lethal toxicity (30 mg/kg, i.v.).

The discovery of YM-60828: a potent, selective and orally-bioavailable factor Xa inhibitor.

Since Factor Xa (FXa) is well known to play a central role in thrombosis and hemostasis, inhibition of FXa is an attractive target for antithrombotic strategies. As a part of our investigation of a non-peptide, orally available FXa inhibitor, we found tha